Breathborne Biomarkers and the Human Volatilome 2020
DOI: 10.1016/b978-0-12-819967-1.00024-4
|View full text |Cite
|
Sign up to set email alerts
|

Biomarkers in urine and stool

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 69 publications
0
4
0
Order By: Relevance
“…It is known that many types of pathologies are characterized by a certain odor and, consequently, by a set of volatile substances. Many substances that are metabolites in pathogenic processes are found in human secretions [ 14 , 15 ]. Therefore, volatile markers were identified in the EGP of urine samples according to identification parameters calculated by Equations (1)–(4).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…It is known that many types of pathologies are characterized by a certain odor and, consequently, by a set of volatile substances. Many substances that are metabolites in pathogenic processes are found in human secretions [ 14 , 15 ]. Therefore, volatile markers were identified in the EGP of urine samples according to identification parameters calculated by Equations (1)–(4).…”
Section: Discussionmentioning
confidence: 99%
“…The choice of sensors for an array is influenced by their high sensitivity to various classes of volatile substances, including volatile biomarkers of diseases in the urine [ 14 , 15 , 16 ]. Films of 18C6, Tween were chosen for the detection of carboxylic and hydroxy acids [ 47 , 48 ], and MCNT, BCB, MR for ammonia and amines [ 49 , 50 , 51 ].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…However even among the three, urine is considered easier and more pleasant to sample than faeces and breath is even easier to give from a patient’s point of view. 10 Therefore targeting VOCs as non-invasive biomarkers of IBD is advantageous as compared with other potential biomarkers such as methylated DNA or microRNAs 11 , 12 and should be more acceptable to patients. This is essential when looking for a biomarker for potential use in disease screening and disease monitoring—it must be relatively cheap, non-invasive, and acceptable to patients, among other characteristics.…”
Section: Introductionmentioning
confidence: 99%